Dr. Jennifer Clay Cather, MD

Dr. Cather practices at Dallas Day Surgery Center in Dallas, Texas.

Dr. Cather's NPI, 1154366417, was assigned on June 19, 2006. Dr. Cather graduated from UT Southwestern Medical Center in 1994. Dr. Cather holds Texas license J9860.

Dr. Cather's primary practice is Dallas Day Surgery Center, at 9101 N Central Expy, Dallas, TX 75231 in Dallas County. The practice phone is (214) 821-8613.

Dr. Cather's primary practice is Dallas Day Surgery Center in Dallas, Texas. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. Cather to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cather practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Cather's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cather is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cather's licenses on file in 2 states: Texas and California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Cather treats.

CMS data shows 29,258 Medicare services from Dr. Cather across 30 procedure codes in 2024, for 2,324 Medicare patients. Medicare paid $672,879 for them. Every service was in an office.

CMS counts 2,324 Medicare patients who saw Dr. Cather in 2024. The largest group is 65 to 74, with 1,202 patients. 75% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cather's median patient age at 58, with 66% women.

In 2024, Dr. Cather wrote 1,230 Medicare Part D claims for 540 patients. 89% of them were for generic drugs. CMS names the drug for 1,042 of them, across 26 drugs with 11 or more claims each, at $332,326 in total drug cost. In 2023, CMS named 799 claims across 23 drugs.

Dr. Cather accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,517 procedures of removal of skin lesions by Dr. Cather, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 64 papers to Dr. Cather, published from 2007 to 2022. 2017 was the busiest year, with 5. The most frequent topics are Psoriasis, Antibodies, Monoclonal, Humanized and Dermatologic Agents. Dr. Cather has published most often in Proc (Bayl Univ Med Cent). Dr. Cather's most frequent co-authors are Jeffrey J. Crowley, MD, Madeleine Duvic, MD and Cindy Noel Berthelot, MD.

Dmand AI links Dr. Cather to 15 clinical trials, 3 of them phase 3 studies. Conditions studied include Dermatitis, Atopic, Eczema and Psoriasis. Eli Lilly and Company sponsors the most, 10. Open Payments lists research payments to Dr. Cather that name 10 trials.

CMS Open Payments shows 2,577 general payments to Dr. Cather from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Eli Lilly and Company paid the most, $589,245. It also lists 51 research payments totaling $123,108 from 2016 to 2024, naming 10 clinical trials.

Dmand AI lists 4 awards for Dr. Cather, most recently America's Top Doctors in 2014.

Dr. Cather graduated from UT Southwestern Medical Center in 1994. Dr. Cather is a member of AAD.

Dr. Cather is in network with 18 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.